Active-ingredient Dossier
Aspirin
Active-ingredient Dossier for Aspirin (nonsteroidal anti-inflammatory drug). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: ASTRIX
- Brand: CARDIPRIN
- Brand: CLOPIDOGREL WINTHROP
- Brand: DUOPLIDOGREL
- Brand: SPREN
- Brand: APX-CLOPIDOGREL/ASPIRIN
- Therapeutic area: Cardiology
- Therapeutic area: Pain Management
- Therapeutic area: Complementary Medicine
What is
Aspirin Aspirin is a nonsteroidal anti-inflammatory drug.
Australian brands containing
Aspirin — ASTRIX — CARDIPRIN — SPREN — CLOPIDOGREL WINTHROP — APX-CLOPIDOGREL/ASPIRIN — ASPALGIN — DUOCOVER — DUOPLIDOGREL — PIAX
Therapeutic areas
Aspirin is registered in five therapeutic areas: Cardiology (10 brands), Neurology (8 brands), Pain & Anaesthesia (4 brands), Pain Management (3 brands), and Complementary Medicine (1 brand).
Sponsor landscape
Aspirin is marketed by 12 sponsors, including Arrotex Pharmaceuticals, Sanofi-Aventis, Bayer, Nova Pharmaceuticals, Reckitt Benckiser, and Medis Pharma.
PBS and regulatory activity
Three brands containing aspirin have PBS-listed items, with the latest PBS schedule date of 1 May 2026. In the 2013–14 financial year, aspirin products generated government expenditure of $36,724,795 across 619,543 prescriptions. The latest PBAC outcome on record dates to 1 March 2008, and the latest AusPAR to 1 September 2009.